OTRK - Ontrak, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Miami,
United States
Type: Equity
OTRK price evolution
OTRK
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7.29 | $6.4 | $9.7 | $9.23 |
| Short term investments | ||||
| Net receivables | $1.33 | $0.47 | $0.21 | $0.56 |
| Inventory | ||||
| Total current assets | $11.12 | $9.43 | $12.78 | $12.68 |
| Long term investments | ||||
| Property, plant & equipment | $0.75 | $0.94 | $1.11 | $1.98 |
| Goodwill & intangible assets | $5.71 | $5.76 | $5.81 | $5.92 |
| Total noncurrent assets | $14.16 | $17.29 | $7.07 | $8.08 |
| Total investments | ||||
| Total assets | $25.27 | $26.72 | $19.85 | $20.77 |
| Current liabilities | ||||
| Accounts payable | $0.22 | $0.67 | $0.56 | $1.14 |
| Deferred revenue | $0.06 | $0.24 | $0.1 | $0.3 |
| Short long term debt | $0.06 | $0.06 | $0.06 | $0.05 |
| Total current liabilities | $3.06 | $3.71 | $3.94 | $11.16 |
| Long term debt | $6.81 | $1.77 | $1.63 | $14.24 |
| Total noncurrent liabilities | $6.81 | $1.77 | $1.63 | $14.24 |
| Total debt | $6.87 | $1.83 | $1.69 | $14.29 |
| Total liabilities | $9.86 | $5.48 | $5.58 | $25.4 |
| Shareholders' equity | ||||
| Retained earnings | -$485.41 | -$475.12 | -$470.66 | -$464.26 |
| Other shareholder equity | ||||
| Total shareholder equity | $15.41 | $21.25 | $14.27 | -$4.63 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $9.7 | $9.51 | $65.54 | $96.03 |
| Short term investments | ||||
| Net receivables | $0.21 | $1.43 | $9.17 | $21.11 |
| Inventory | ||||
| Total current assets | $12.78 | $14.26 | $80.33 | $123.64 |
| Long term investments | $0.2 | $0.41 | $7.18 | |
| Property, plant & equipment | $1.11 | $3.13 | $4.44 | $4.23 |
| Goodwill & intangible assets | $5.81 | $6.84 | $8.06 | $9.29 |
| Total noncurrent assets | $7.07 | $11.5 | $13.35 | $21.06 |
| Total investments | $0.2 | $0.41 | $7.18 | |
| Total assets | $19.85 | $25.76 | $93.68 | $144.7 |
| Current liabilities | ||||
| Accounts payable | $0.56 | $1.93 | $1 | $1.29 |
| Deferred revenue | $0.1 | $0.33 | $0.44 | $20.95 |
| Short long term debt | $0.06 | $0.65 | $0.59 | $0.43 |
| Total current liabilities | $3.94 | $9.47 | $10.33 | $36.41 |
| Long term debt | $1.63 | $10.61 | $36.86 | $47.54 |
| Total noncurrent liabilities | $1.63 | $10.61 | $37.79 | $47.54 |
| Total debt | $1.69 | $11.26 | $37.45 | $47.97 |
| Total liabilities | $5.58 | $20.08 | $48.13 | $83.95 |
| Shareholders' equity | ||||
| Retained earnings | -$470.66 | -$442.74 | -$391.17 | -$354.02 |
| Other shareholder equity | ||||
| Total shareholder equity | $14.27 | $5.68 | $45.55 | $60.75 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.45 | $2.68 | $3.54 | $3.71 |
| Cost of revenue | $0.84 | $0.97 | $1.25 | $1.04 |
| Gross Profit | $1.61 | $1.71 | $2.29 | $2.67 |
| Operating activities | ||||
| Research & development | $1.03 | $1.08 | $1.89 | $1.55 |
| Selling, general & administrative | $4.63 | $4.61 | $5.61 | $5.19 |
| Total operating expenses | $5.65 | $5.98 | $7.5 | $6.74 |
| Operating income | -$4.05 | -$4.27 | -$5.21 | -$4.06 |
| Income from continuing operations | ||||
| EBIT | -$9.96 | -$4.28 | -$5.2 | -$4.03 |
| Income tax expense | ||||
| Interest expense | $0.33 | $0.18 | $1.19 | $2.39 |
| Net income | ||||
| Net income | -$10.29 | -$4.46 | -$6.4 | -$6.42 |
| Income (for common shares) | -$12.53 | -$6.7 | -$8.63 | -$8.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12.74 | $14.51 | $84.13 | $82.84 |
| Cost of revenue | $3.94 | $7.46 | $31.21 | $43.6 |
| Gross Profit | $8.8 | $7.05 | $52.92 | $39.23 |
| Operating activities | ||||
| Research & development | $6.63 | $10.97 | $18.28 | $12.92 |
| Selling, general & administrative | $22.85 | $39.26 | $53.67 | $41.23 |
| Total operating expenses | $29.93 | $51.17 | $80.9 | $54.16 |
| Operating income | -$21.13 | -$44.12 | -$27.98 | -$14.92 |
| Income from continuing operations | ||||
| EBIT | -$20.8 | -$47.58 | -$28.99 | -$16.14 |
| Income tax expense | -$0.08 | $0.09 | $0.15 | -$0.65 |
| Interest expense | $7.2 | $3.91 | $8 | $7.22 |
| Net income | ||||
| Net income | -$27.92 | -$51.57 | -$37.14 | -$22.71 |
| Income (for common shares) | -$36.87 | -$60.53 | -$46.1 | -$24.7 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$10.29 | -$4.46 | -$6.4 | -$6.42 |
| Operating activities | ||||
| Depreciation | $0.32 | $0.3 | $1.58 | $1.83 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.44 | $0.35 | $0.61 | $0.8 |
| Total cash flows from operations | -$4.47 | -$3.26 | -$3.62 | -$1.81 |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$0.04 | -$0.09 | -$0.07 |
| Investments | ||||
| Total cash flows from investing | -$0.04 | -$0.04 | -$0.09 | -$0.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.44 | $0.52 | $6.3 | |
| Net borrowings | $3.96 | -$0.53 | -$6.38 | $1.02 |
| Total cash flows from financing | $5.4 | -$0.01 | $4.18 | $1.02 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.89 | -$3.3 | $0.47 | -$0.87 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$27.92 | -$51.57 | -$37.14 | -$22.71 |
| Operating activities | ||||
| Depreciation | $6.38 | $5.2 | $4.01 | $1.93 |
| Business acquisitions & disposals | -$2.88 | |||
| Stock-based compensation | $2.95 | $8.16 | $12.96 | $8.82 |
| Total cash flows from operations | -$15.5 | -$23.97 | -$26.16 | -$6.28 |
| Investing activities | ||||
| Capital expenditures | -$0.28 | -$1.16 | -$4.48 | -$1.76 |
| Investments | ||||
| Total cash flows from investing | -$0.28 | -$1.16 | -$4.48 | -$4.64 |
| Financing activities | ||||
| Dividends paid | -$2.24 | -$8.95 | -$1.24 | |
| Sale and purchase of stock | $6.3 | $3.29 | $16.51 | $6.3 |
| Net borrowings | $5.22 | -$32.16 | -$14.16 | $8.5 |
| Total cash flows from financing | $15.77 | -$31.11 | -$6.63 | $100.11 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.01 | -$56.23 | -$37.26 | $89.19 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $12.38M |
|---|---|
| EBITDA | -$19.44M |
| EBIT | -$23.47M |
| Net Income | -$27.56M |
| Revenue Q/Q | -17.20% |
| Revenue Y/Y | 14.23% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -119.04% |
| ROE | -238.10% |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | -0.13 |
| Current ratio | 3.64 |
| Quick ratio | 3.64 |